O. Vesga

发表

Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: an observational study

Andres F Zuluaga, F. Jaimes, W. Galvis, 2002, BMC infectious diseases.

Determination of Therapeutic Equivalence of Generic Products of Gentamicin in the Neutropenic Mouse Thigh Infection Model

C. A. Rodriguez, Andres F Zuluaga, O. Vesga, 2010, PloS one.

Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam

C. A. Rodriguez, Andres F Zuluaga, O. Vesga, 2016, PloS one.

Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin

C. A. Rodriguez, Andres F Zuluaga, O. Vesga, 2019, PloS one.

In Vivo Pharmacodynamic Activities of Two Glycylcyclines (GAR-936 and WAY 152,288) against Various Gram-Positive and Gram-Negative Bacteria

W. Craig, D. Andes, W. Weiss, 2000, Antimicrobial Agents and Chemotherapy.

A new pharmacodynamic approach to study antibiotic combinations against enterococci in vivo: Application to ampicillin plus ceftriaxone

C. A. Rodriguez, Andres F Zuluaga, O. Vesga, 2020, PloS one.

Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam.

C. A. Rodriguez, Andres F Zuluaga, O. Vesga, 2015, International journal of antimicrobial agents.

[Vancomycin-resistant Staphylococcus aureus].

C. A. Rodriguez, O. Vesga, C. Rodriguez, 2005, Biomedica : revista del Instituto Nacional de Salud.

Antifungal pharmacodynamics: Latin America's perspective

C. A. Rodriguez, Andres F Zuluaga, Javier M. González, 2016, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections.

R. Proctor, O. Vesga, J. M. Balwit, 1994, Infectious agents and disease.

Etiologic Diagnosis of Chronic Osteomyelitis

J. Saldarriaga, Andres F Zuluaga, W. Galvis, 2017 .

Etiologic diagnosis of chronic osteomyelitis: a prospective study.

J. Saldarriaga, Andres F Zuluaga, W. Galvis, 2006, Archives of internal medicine.

Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis

Andres F Zuluaga, Javier M. González, O. Vesga, 2015, PloS one.

Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia.

Andres F Zuluaga, O. Vesga, M. Agudelo, 2009, The Journal of infection.

Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics

Andres F Zuluaga, O. Vesga, M. Agudelo, 2009, BMC clinical pharmacology.

Impact on Resistance of the Use of Therapeutically Equivalent Generics: the Case of Ciprofloxacin

Andres F Zuluaga, O. Vesga, M. Agudelo, 2014, Antimicrobial Agents and Chemotherapy.

Even Apparently Insignificant Chemical Deviations among Bioequivalent Generic Antibiotics Can Lead to Therapeutic Nonequivalence: the Case of Meropenem

O. Vesga, C. Pelaez, M. Agudelo, 2013, Antimicrobial Agents and Chemotherapy.

generic antibiotics can lead to therapeutic nonequivalence: the case of

O. Vesga, C. Pelaez, M. Agudelo, 2013 .

Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the Innovator

Andres F Zuluaga, O. Vesga, M. Agudelo, 2010, Antimicrobial Agents and Chemotherapy.

Open Access Research Article

Andres F Zuluaga, O. Vesga, M. Agudelo, 2022 .

About the validation of animal models to study the pharmacodynamics of generic antimicrobials.

Andres F Zuluaga, O. Vesga, M. Agudelo, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products.

Andres F Zuluaga, O. Vesga, M. Agudelo, 2017, International journal of antimicrobial agents.

Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC Breakpoint

G. Drusano, W. Craig, D. Andes, 2001, Antimicrobial Agents and Chemotherapy.

Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases

Andres F Zuluaga, Beatriz E Salazar, Carlos A Rodriguez, 2006, BMC infectious diseases.

Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu.

R. Proctor, O. Vesga, M. Groeschel, 1996, The Journal of infectious diseases.

Staphylococcus aureus Small Colony Variants Cause Persistent and Resistant Infections

H. Sahl, R. Proctor, A. Bayer, 1996 .

An Optimized Mouse Thigh Infection Model for Enterococci and Its Impact on Antimicrobial Pharmacodynamics

Andres F Zuluaga, Javier M. González, O. Vesga, 2014, Antimicrobial Agents and Chemotherapy.

FOUNDATION OF A FUNCTIONAL MURINE PATHOGEN FREE ANIMAL FACILITY IN COLOMBIA

W. Galvis, O. Vesga, M. Agudelo, 2003 .

Dog Savior: Immediate Scent-Detection of SARS-COV-2 by Trained Dogs

Andrés F. Valencia, J. Hernandez-Ortiz, J. Osorio, 2020, bioRxiv.

Generic Vancomycin Enriches Resistant Subpopulations of Staphylococcus aureus after Exposure in a Neutropenic Mouse Thigh Infection Model

Andres F Zuluaga, O. Vesga, M. Agudelo, 2011, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model

Andres F Zuluaga, O. Vesga, M. Agudelo, 2015, BMC Research Notes.

Therapeutic Equivalence Requires Pharmaceutical, Pharmacokinetic, and Pharmacodynamic Identities: True Bioequivalence of a Generic Product of Intravenous Metronidazole

O. Vesga, M. Agudelo, 2012, Antimicrobial Agents and Chemotherapy.

A strain-independent method to induce progressive and lethal pneumococcal pneumonia in neutropenic mice

Andres F Zuluaga, O. Vesga, M. Agudelo, 2015, Journal of Biomedical Science.

Highly sensitive scent-detection of COVID-19 patients in vivo by trained dogs

J. Hernandez-Ortiz, J. Osorio, O. Vesga, 2021, medRxiv.

Optimization of culture conditions to obtain maximal growth of penicillin-resistant Streptococcus pneumoniae

Andres F Zuluaga, A. Restrepo, O. Vesga, 2005, BMC Microbiology.

Pharmacokinetic/Pharmacodynamic Index Linked to In Vivo Efficacy of the Ampicillin-Ceftriaxone Combination against Enterococcus faecalis

Andres F Zuluaga, O. Vesga, J. D. Otalvaro, 2023, Antimicrobial agents and chemotherapy.

[Vancomycin-resistant Staphylococcus aureus].

O. Vesga, C. Rodriguez, Omar Vesga, 2005 .

Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam

Andres F Zuluaga, O. Vesga, Yudy Aguilar, 2016, PloS one.

About the validation of animal models to study the pharmacodynamics of generic antimicrobials.

Andres F Zuluaga, O. Vesga, C. Rodriguez, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model

Andres F Zuluaga, O. Vesga, C. Rodriguez, 2015, BMC Research Notes.

Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases

Andres F Zuluaga, O. Vesga, Beatriz E. Salazar, 2006, BMC infectious diseases.

In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin

Andres F Zuluaga, O. Vesga, C. Rodriguez, 2010, BMC infectious diseases.